Aktienanalyse zu Waldencast PLC (WALD)WALDWaldencast PLC

Waldencast plc is a global multi-brand beauty and wellness platform. It is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical segment sells advanced skincare products backed by science and formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and to protect and enhance skin tone and texture. Its portfolio of medical-grade skincare with consumer-centric, in-office injectable procedures includes Saypha ChIQ, and MagIQ lines of injectable hyaluronic acid gels. The Milk Makeup segment consists of the business of Milk. Its Milk’s business activities include developing, marketing, and selling cosmetics, skincare, and other beauty products. Its Milk Makeup segment offers over 250 products through its United States Website www.MilkMakeup.com and retail partners include Sephora globally and Ulta Beauty in the United States. It operates in the Consumer Cyclicals sector (PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS industry).

Waldencast PLC is not a good buy right now due to significant financial losses and declining stock performance. The current price is $0.88, which is down 48.57% year-to-date. The RSI is at 26.413, indicating that the stock is oversold, but the forward P/E ratio is extremely high at 45.045, suggesting that the stock may be overvalued relative to its earnings potential. The main risk is the net margin, which was -140.03% in Q2 2025, indicating severe profitability issues.